ESC 365 - Professor Gerrit Frommeyer

Speaker illustration

Professor Gerrit Frommeyer

University Hospital of Munster, Munster (Germany)

Deputy Head of Clinic for Cardiology II - Electrophysiology. University of Muenster, Germany.

Safe electrophysiologic profile of the neprilysin-inhibitor sacubitril in combination with different antiarrhythmic drugs

Event: ESC Congress 2022

Topic: Drug Treatment of Ventricular Arrhythmias

Session: Pharmacological and metabolic impact on ventricular arrhythmias

Divergent electrophysiologic safety profile of dapagliflozin and empagliflozin in a whole-heart model

Event: ESC Congress 2022

Topic: Arrhythmias

Session: Mechanisms of atrial and ventricular arrhythmias

Dapagliflozin but not empagliflozin prevents atrial fibrillation in an experimental whole-heart model

Event: ESC Congress 2022

Topic: Cellular Electrophysiology

Session: Insights into arrhythmia mechanisms

Beneficial electrophysiologic effects of sacubitril in different arrhythmia syndromes

Event: ESC Congress 2020

Topic: Pathophysiology and Mechanisms

Session: Arrhythmias, General ePosters

Dexmedetomidine reduces ventricular arrhythmias in a model of drug-induced QT-prolongation

Event: ESC Congress 2020

Topic: Antiarrhythmic Drug Treatment

Session: Arrhythmias, General ePosters

Arrhythmogenic effects of non-steroidal anti-inflammatory drugs (NSAID)

Event: ESC Congress 2019

Topic: Risk Factors and Risk Assessment

Session: Basic Science

Time-to-isolation-guided cryoballoon pulmonary vein isolation reduces esophageal and mediastinal alterations detected by endoscopic ultrasound

Event: ESC Congress 2019

Topic: Rhythm Control, Catheter Ablation

Session: New insights in atrial fibrillation ablation: techniques and complications

Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy - data from the German device Registry

Event: ESC Congress 2019

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Arrhythmia in cardiomyopathy

Long-term single-center experience of transvenous defibrillator therapy in children and adolescents

Event: ESC Congress 2018

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Implantable cardioverter defibrillation : treatment outcomes

Ranolazine reduces levosimendan-mediated atrial fibrillation in an experimental whole-heart model

Event: ESC Congress 2018

Topic: Antiarrhythmic Drug Treatment

Session: Arrhythmia mechanisms - General

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources